Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1988-08-03
1991-10-15
Richter, Johann
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
43524026, C07K 1300, C12N 500
Patent
active
050576046
ABSTRACT:
A monoclonal antibody which specifically reconizes a receptor that binds to proteins that contain the amino acid sequence Arg-Gly-Asp which on binding said proteins causes the cells to become substantially more phagocytic.
REFERENCES:
Hynes, Cell 48, 549-554 (1987).
Hemler et al., J. Biol. Chem. 262, 3300-3309 (1987).
Ginsberg et al., Thromb. Hemostasis, 59, 1-6 (1988).
Anderson & Springer, Ann. Rev. Med. 38, 175-194 (1987).
Brown & Goodwin, J. Exp. Med. 167, 777-793 (1988).
Wright & Meyer, J. Exp. Med. 162, 762-767 (1985).
Pierschbacher, Science, 238, 491-497 (1987).
Meyer Scott J.
Richter Johann
Washington University
Williams, Jr. James W.
LandOfFree
Novel monoclonal antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel monoclonal antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel monoclonal antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-992166